A great deal of confusion and uncertainty over genotoxic impurity (GTI) identification, assessment, and control exists in the pharmaceutical industry today. Pharmaceutical Industry Practices on Genotoxic Impurities strives to facilitate scientific and systematic consensus on GTI management by presenting rationales, strategies, methods, interpretati
Overview
Select a Delivery Option
Pharmaceutical Industry Practices on Genotoxic Impurities
1 Item Added to Bag 1 Item Added to Pickup